Global Iron Drugs Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	174 Pages	TechNavio	June, 2024	INF19007185

Best Price Guarantee
Price	from $2,500
Length	174 Pages
Publisher	TechNavio
Published Date	June, 2024
SKU	INF19007185

Global Iron Drugs Market 2024-2028

The iron drugs market is forecasted to grow by USD 4582.1 mn during 2023-2028, accelerating at a CAGR of 10.87% during the forecast period. The report on the iron drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of iron deficiency globally, growing awareness about importance of iron in maintaining overall health, and growing geriatric population.

Technavio's iron drugs market is segmented as below:

By Product

Oral drug
IV drug

By Age Group

Adult
Pediatric

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing number of CKD dialysis centers in emerging economies as one of the prime reasons driving the iron drugs market growth during the next few years. Also, growing recent developments related to iron drugs and increasing use of iron supplements in pregnancy will lead to sizable demand in the market.

The report on the iron drugs market covers the following areas:

Iron drugs market sizing
Iron drugs market forecast
Iron drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading iron drugs market vendors that include Abbott Laboratories, AbbVie Inc., Alinter Group Ltd., Alora Pharmaceuticals LLC, Breckenridge Pharmaceutical Inc., Covis Pharma GmbH, CSL Ltd., Daiichi Sankyo Co. Ltd., DSE Health Care Solutions Inc., GlaxoSmithKline PLC, Hiral Labs Ltd., McKesson Corp., NovaFerrum, Pharmacosmos AS, The Procter and Gamble Co., Reckitt Benckiser Group PLC, Rockwell Medical Inc., Sanofi SA, Shield Therapeutics PLC, and Zydus Lifesciences Ltd.. Also, the iron drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by Age Group; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Iron Drugs Market 2018 - 2022; Historic Market Size - Data Table on Global Iron Drugs Market 2018 - 2022 ($ million); 4.2 Product segment analysis 2018 - 2022; Historic Market Size - Product Segment 2018 - 2022 ($ million); 4.3 Age Group segment analysis 2018 - 2022; Historic Market Size - Age Group Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product: 6.1 Market segments; Chart on Product - Market share 2023-2028 (%); Data Table on Product - Market share 2023-2028 (%); 6.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 6.3 Oral drug - Market size and forecast 2023-2028; Chart on Oral drug - Market size and forecast 2023-2028 ($ million); Data Table on Oral drug - Market size and forecast 2023-2028 ($ million); Chart on Oral drug - Year-over-year growth 2023-2028 (%); Data Table on Oral drug - Year-over-year growth 2023-2028 (%); 6.4 IV drug - Market size and forecast 2023-2028; Chart on IV drug - Market size and forecast 2023-2028 ($ million); Data Table on IV drug - Market size and forecast 2023-2028 ($ million); Chart on IV drug - Year-over-year growth 2023-2028 (%); Data Table on IV drug - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Product; Market opportunity by Product ($ million); Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Age Group: 7.1 Market segments; Chart on Age Group - Market share 2023-2028 (%); Data Table on Age Group - Market share 2023-2028 (%); 7.2 Comparison by Age Group; Chart on Comparison by Age Group; Data Table on Comparison by Age Group; 7.3 Adult - Market size and forecast 2023-2028; Chart on Adult - Market size and forecast 2023-2028 ($ million); Data Table on Adult - Market size and forecast 2023-2028 ($ million); Chart on Adult - Year-over-year growth 2023-2028 (%); Data Table on Adult - Year-over-year growth 2023-2028 (%); 7.4 Pediatric - Market size and forecast 2023-2028; Chart on Pediatric - Market size and forecast 2023-2028 ($ million); Data Table on Pediatric - Market size and forecast 2023-2028 ($ million); Chart on Pediatric - Year-over-year growth 2023-2028 (%); Data Table on Pediatric - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Age Group; Market opportunity by Age Group ($ million); Data Table on Market opportunity by Age Group ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.9 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.10 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.11 France - Market size and forecast 2023-2028; Chart on France - Market size and forecast 2023-2028 ($ million); Data Table on France - Market size and forecast 2023-2028 ($ million); Chart on France - Year-over-year growth 2023-2028 (%); Data Table on France - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Abbott Laboratories; Abbott Laboratories - Overview; Abbott Laboratories - Business segments; Abbott Laboratories - Key news; Abbott Laboratories - Key offerings; Abbott Laboratories - Segment focus; 12.4 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; 12.5 Covis Pharma GmbH; Covis Pharma GmbH - Overview; Covis Pharma GmbH - Product / Service; Covis Pharma GmbH - Key offerings; 12.6 CSL Ltd.; CSL Ltd. - Overview; CSL Ltd. - Business segments; CSL Ltd. - Key news; CSL Ltd. - Key offerings; CSL Ltd. - Segment focus; 12.7 Daiichi Sankyo Co. Ltd.; Daiichi Sankyo Co. Ltd. - Overview; Daiichi Sankyo Co. Ltd. - Product / Service; Daiichi Sankyo Co. Ltd. - Key news; Daiichi Sankyo Co. Ltd. - Key offerings; 12.8 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; 12.9 Hiral Labs Ltd.; Hiral Labs Ltd. - Overview; Hiral Labs Ltd. - Product / Service; Hiral Labs Ltd. - Key offerings; 12.10 McKesson Corp.; McKesson Corp. - Overview; McKesson Corp. - Business segments; McKesson Corp. - Key news; McKesson Corp. - Key offerings; McKesson Corp. - Segment focus; 12.11 Pharmacosmos AS; Pharmacosmos AS - Overview; Pharmacosmos AS - Product / Service; Pharmacosmos AS - Key offerings; 12.12 The Procter and Gamble Co.; The Procter and Gamble Co. - Overview; The Procter and Gamble Co. - Business segments; The Procter and Gamble Co. - Key news; The Procter and Gamble Co. - Key offerings; The Procter and Gamble Co. - Segment focus; 12.13 Reckitt Benckiser Group Plc; Reckitt Benckiser Group Plc - Overview; Reckitt Benckiser Group Plc - Business segments; Reckitt Benckiser Group Plc - Key news; Reckitt Benckiser Group Plc - Key offerings; Reckitt Benckiser Group Plc - Segment focus; 12.14 Rockwell Medical Inc.; Rockwell Medical Inc. - Overview; Rockwell Medical Inc. - Product / Service; Rockwell Medical Inc. - Key offerings; 12.15 Sanofi SA; Sanofi SA - Overview; Sanofi SA - Business segments; Sanofi SA - Key news; Sanofi SA - Key offerings; Sanofi SA - Segment focus; 12.16 Shield Therapeutics plc; Shield Therapeutics plc - Overview; Shield Therapeutics plc - Product / Service; Shield Therapeutics plc - Key offerings; 12.17 Zydus Lifesciences Ltd.; Zydus Lifesciences Ltd. - Overview; Zydus Lifesciences Ltd. - Business segments; Zydus Lifesciences Ltd. - Key news; Zydus Lifesciences Ltd. - Key offerings; Zydus Lifesciences Ltd. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations

Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by Age Group; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Iron Drugs Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Age Group Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Product - Market share 2023-2028 (%); Exhibits33: Data Table on Product - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Product; Exhibits35: Data Table on Comparison by Product; Exhibits36: Chart on Oral drug - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Oral drug - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Oral drug - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Oral drug - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on IV drug - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on IV drug - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on IV drug - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on IV drug - Year-over-year growth 2023-2028 (%); Exhibits44: Market opportunity by Product ($ million); Exhibits45: Data Table on Market opportunity by Product ($ million); Exhibits46: Chart on Age Group - Market share 2023-2028 (%); Exhibits47: Data Table on Age Group - Market share 2023-2028 (%); Exhibits48: Chart on Comparison by Age Group; Exhibits49: Data Table on Comparison by Age Group; Exhibits50: Chart on Adult - Market size and forecast 2023-2028 ($ million); Exhibits51: Data Table on Adult - Market size and forecast 2023-2028 ($ million); Exhibits52: Chart on Adult - Year-over-year growth 2023-2028 (%); Exhibits53: Data Table on Adult - Year-over-year growth 2023-2028 (%); Exhibits54: Chart on Pediatric - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Pediatric - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Pediatric - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Pediatric - Year-over-year growth 2023-2028 (%); Exhibits58: Market opportunity by Age Group ($ million); Exhibits59: Data Table on Market opportunity by Age Group ($ million); Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits63: Chart on Geographic comparison; Exhibits64: Data Table on Geographic comparison; Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on France - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on France - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits101: Market opportunity By Geographical Landscape ($ million); Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits103: Impact of drivers and challenges in 2023 and 2028; Exhibits104: Overview on criticality of inputs and factors of differentiation; Exhibits105: Overview on factors of disruption; Exhibits106: Impact of key risks on business; Exhibits107: Companies covered; Exhibits108: Matrix on companies position and classification; Exhibits109: Abbott Laboratories - Overview; Exhibits110: Abbott Laboratories - Business segments; Exhibits111: Abbott Laboratories - Key news; Exhibits112: Abbott Laboratories - Key offerings; Exhibits113: Abbott Laboratories - Segment focus; Exhibits114: AbbVie Inc. - Overview; Exhibits115: AbbVie Inc. - Product / Service; Exhibits116: AbbVie Inc. - Key news; Exhibits117: AbbVie Inc. - Key offerings; Exhibits118: Covis Pharma GmbH - Overview; Exhibits119: Covis Pharma GmbH - Product / Service; Exhibits120: Covis Pharma GmbH - Key offerings; Exhibits121: CSL Ltd. - Overview; Exhibits122: CSL Ltd. - Business segments; Exhibits123: CSL Ltd. - Key news; Exhibits124: CSL Ltd. - Key offerings; Exhibits125: CSL Ltd. - Segment focus; Exhibits126: Daiichi Sankyo Co. Ltd. - Overview; Exhibits127: Daiichi Sankyo Co. Ltd. - Product / Service; Exhibits128: Daiichi Sankyo Co. Ltd. - Key news; Exhibits129: Daiichi Sankyo Co. Ltd. - Key offerings; Exhibits130: GlaxoSmithKline Plc - Overview; Exhibits131: GlaxoSmithKline Plc - Business segments; Exhibits132: GlaxoSmithKline Plc - Key news; Exhibits133: GlaxoSmithKline Plc - Key offerings; Exhibits134: GlaxoSmithKline Plc - Segment focus; Exhibits135: Hiral Labs Ltd. - Overview; Exhibits136: Hiral Labs Ltd. - Product / Service; Exhibits137: Hiral Labs Ltd. - Key offerings; Exhibits138: McKesson Corp. - Overview; Exhibits139: McKesson Corp. - Business segments; Exhibits140: McKesson Corp. - Key news; Exhibits141: McKesson Corp. - Key offerings; Exhibits142: McKesson Corp. - Segment focus; Exhibits143: Pharmacosmos AS - Overview; Exhibits144: Pharmacosmos AS - Product / Service; Exhibits145: Pharmacosmos AS - Key offerings; Exhibits146: The Procter and Gamble Co. - Overview; Exhibits147: The Procter and Gamble Co. - Business segments; Exhibits148: The Procter and Gamble Co. - Key news; Exhibits149: The Procter and Gamble Co. - Key offerings; Exhibits150: The Procter and Gamble Co. - Segment focus; Exhibits151: Reckitt Benckiser Group Plc - Overview; Exhibits152: Reckitt Benckiser Group Plc - Business segments; Exhibits153: Reckitt Benckiser Group Plc - Key news; Exhibits154: Reckitt Benckiser Group Plc - Key offerings; Exhibits155: Reckitt Benckiser Group Plc - Segment focus; Exhibits156: Rockwell Medical Inc. - Overview; Exhibits157: Rockwell Medical Inc. - Product / Service; Exhibits158: Rockwell Medical Inc. - Key offerings; Exhibits159: Sanofi SA - Overview; Exhibits160: Sanofi SA - Business segments; Exhibits161: Sanofi SA - Key news; Exhibits162: Sanofi SA - Key offerings; Exhibits163: Sanofi SA - Segment focus; Exhibits164: Shield Therapeutics plc - Overview; Exhibits165: Shield Therapeutics plc - Product / Service; Exhibits166: Shield Therapeutics plc - Key offerings; Exhibits167: Zydus Lifesciences Ltd. - Overview; Exhibits168: Zydus Lifesciences Ltd. - Business segments; Exhibits169: Zydus Lifesciences Ltd. - Key news; Exhibits170: Zydus Lifesciences Ltd. - Key offerings; Exhibits171: Zydus Lifesciences Ltd. - Segment focus; Exhibits172: Inclusions checklist; Exhibits173: Exclusions checklist; Exhibits174: Currency conversion rates for US$; Exhibits175: Research methodology; Exhibits176: Information sources; Exhibits177: Data validation; Exhibits178: Validation techniques employed for market sizing; Exhibits179: Data synthesis; Exhibits180: 360 degree market analysis; Exhibits181: List of abbreviations